MARKER THERAPEUTICS, INC. Construction in Progress, Gross
MARKER THERAPEUTICS, INC. (MRKR) had Construction in Progress, Gross of $0 as of 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:ConstructionInProgressGross · last filed 2023-03-22
- 2022-12-31: Construction in Progress, Gross $0.00.
- 2022-06-30: Construction in Progress, Gross $0.00.
- 2022-03-31: Construction in Progress, Gross $4.09M.
- 2021-12-31: Construction in Progress, Gross $2.23M.
| Period end | Construction in Progress, Gross |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-22 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 |
| 2022-03-31 | $4.09M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $2.23M 10-K · filed 2023-03-22 |
| 2021-09-30 | $600.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-10 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 |
| 2020-12-31 | $6.79M 10-K · filed 2022-03-17 |
| 2020-09-30 | $4.56M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $2.63M 10-Q · filed 2020-08-10 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |